246 related articles for article (PubMed ID: 36948992)
1. Autoimmune manifestations in VEXAS: Opportunities for integration and pitfalls to interpretation.
Bruno A; Gurnari C; Alexander T; Snowden JA; Greco R;
J Allergy Clin Immunol; 2023 May; 151(5):1204-1214. PubMed ID: 36948992
[TBL] [Abstract][Full Text] [Related]
2. Allogeneic stem cell transplantation as a curative therapeutic approach for VEXAS syndrome: a case report.
Loschi M; Roux C; Sudaka I; Ferrero-Vacher C; Marceau-Renaut A; Duployez N; Passeron T; Cluzeau T
Bone Marrow Transplant; 2022 Feb; 57(2):315-318. PubMed ID: 34999727
[TBL] [Abstract][Full Text] [Related]
3. Update on VEXAS and role of allogeneic bone marrow transplant: Considerations on behalf of the Chronic Malignancies Working Party of the EBMT.
Gurnari C; McLornan DP
Bone Marrow Transplant; 2022 Nov; 57(11):1642-1648. PubMed ID: 35941354
[TBL] [Abstract][Full Text] [Related]
4. Successful allogeneic hematopoietic stem cell transplantation in patients with VEXAS syndrome: a 2-center experience.
Diarra A; Duployez N; Fournier E; Preudhomme C; Coiteux V; Magro L; Quesnel B; Heiblig M; Sujobert P; Barraco F; Balsat M; Scanvion Q; Hachulla E; Launay D; Yakoub-Agha I; Terriou L
Blood Adv; 2022 Feb; 6(3):998-1003. PubMed ID: 34714914
[TBL] [Abstract][Full Text] [Related]
5. Vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic syndrome (VEXAS syndrome) with prominent supraglottic larynx involvement: a case-based review.
Guerrero-Bermúdez CA; Cardona-Cardona AF; Ariza-Parra EJ; Arostegui JI; Mensa-Vilaro A; Yague J; Vásquez G; Muñoz-Vahos CH
Clin Rheumatol; 2022 Nov; 41(11):3565-3572. PubMed ID: 35986821
[TBL] [Abstract][Full Text] [Related]
6. [Two cases of VEXAS syndrome].
Gunnarsson K; Vivar Pomiano N; Tesi B; Tobiasson M; Creignou M; Ungerstedt J
Lakartidningen; 2022 Sep; 119():. PubMed ID: 36082915
[TBL] [Abstract][Full Text] [Related]
7. JAK inhibitors for the treatment of VEXAS syndrome.
Bindoli S; Baggio C; Doria A; Bertoldo E; Sfriso P
Exp Biol Med (Maywood); 2023 May; 248(5):394-398. PubMed ID: 37243340
[TBL] [Abstract][Full Text] [Related]
8. An update on VEXAS syndrome.
Al-Hakim A; Savic S
Expert Rev Clin Immunol; 2023 Feb; 19(2):203-215. PubMed ID: 36537591
[TBL] [Abstract][Full Text] [Related]
9. VEXAS Syndrome: A Novelty in MDS Landscape.
Templé M; Kosmider O
Diagnostics (Basel); 2022 Jun; 12(7):. PubMed ID: 35885496
[TBL] [Abstract][Full Text] [Related]
10. VEXAS syndrome.
Nakajima H; Kunimoto H
Int J Hematol; 2024 May; ():. PubMed ID: 38819628
[TBL] [Abstract][Full Text] [Related]
11. Somatic Mutations in UBA1 Define a Distinct Subset of Relapsing Polychondritis Patients With VEXAS.
Ferrada MA; Sikora KA; Luo Y; Wells KV; Patel B; Groarke EM; Ospina Cardona D; Rominger E; Hoffmann P; Le MT; Deng Z; Quinn KA; Rose E; Tsai WL; Wigerblad G; Goodspeed W; Jones A; Wilson L; Schnappauf O; Laird RS; Kim J; Allen C; Sirajuddin A; Chen M; Gadina M; Calvo KR; Kaplan MJ; Colbert RA; Aksentijevich I; Young NS; Savic S; Kastner DL; Ombrello AK; Beck DB; Grayson PC
Arthritis Rheumatol; 2021 Oct; 73(10):1886-1895. PubMed ID: 33779074
[TBL] [Abstract][Full Text] [Related]
12. VEXAS Syndrome-Review.
Zhang Y; Dong X; Wang H
Glob Med Genet; 2023 Sep; 10(3):133-143. PubMed ID: 37501758
[TBL] [Abstract][Full Text] [Related]
13. Thrombotic manifestations of VEXAS syndrome.
Groarke EM; Dulau-Florea AE; Kanthi Y
Semin Hematol; 2021 Oct; 58(4):230-238. PubMed ID: 34802545
[TBL] [Abstract][Full Text] [Related]
14. Benign and malignant hematologic manifestations in patients with VEXAS syndrome due to somatic mutations in UBA1.
Obiorah IE; Patel BA; Groarke EM; Wang W; Trick M; Ombrello AK; Ferrada MA; Wu Z; Gutierrez-Rodrigues F; Lotter J; Wilson L; Hoffmann P; Cardona DO; Patel N; Dulau-Florea A; Kastner DL; Grayson PC; Beck DB; Young NS; Calvo KR
Blood Adv; 2021 Aug; 5(16):3203-3215. PubMed ID: 34427584
[TBL] [Abstract][Full Text] [Related]
15. VEXAS syndrome: An update.
Khitri MY; Hadjadj J; Mekinian A; Jachiet V
Joint Bone Spine; 2024 Feb; 91(4):105700. PubMed ID: 38307404
[TBL] [Abstract][Full Text] [Related]
16. VEXAS syndrome: Clinical, hematologic features and a practical approach to diagnosis and management.
Koster MJ; Lasho TL; Olteanu H; Reichard KK; Mangaonkar A; Warrington KJ; Patnaik MM
Am J Hematol; 2024 Feb; 99(2):284-299. PubMed ID: 37950858
[TBL] [Abstract][Full Text] [Related]
17. Clinical Manifestations in Vacuoles, E1 Enzyme, X-Linked, Autoinflammatory, Somatic (VEXAS) Syndrome: A Narrative Review.
Padureanu V; Marinaș CM; Bobirca A; Padureanu R; Patrascu S; Dascalu AM; Bobirca F; Tribus L; Alexandru C; Serboiu C; Dumitrascu C; Musetescu A
Cureus; 2024 Jan; 16(1):e53041. PubMed ID: 38410307
[TBL] [Abstract][Full Text] [Related]
18. Early activation of inflammatory pathways in UBA1-mutated hematopoietic stem and progenitor cells in VEXAS.
Wu Z; Gao S; Gao Q; Patel BA; Groarke EM; Feng X; Manley AL; Li H; Ospina Cardona D; Kajigaya S; Alemu L; Quinones Raffo D; Ombrello AK; Ferrada MA; Grayson PC; Calvo KR; Kastner DL; Beck DB; Young NS
Cell Rep Med; 2023 Aug; 4(8):101160. PubMed ID: 37586319
[TBL] [Abstract][Full Text] [Related]
19. Novel causative variants of VEXAS in UBA1 detected through whole genome transcriptome sequencing in a large cohort of hematological malignancies.
Sakuma M; Blombery P; Meggendorfer M; Haferlach C; Lindauer M; Martens UM; Kern W; Haferlach T; Walter W
Leukemia; 2023 May; 37(5):1080-1091. PubMed ID: 36823397
[TBL] [Abstract][Full Text] [Related]
20. Estimated Prevalence and Clinical Manifestations of UBA1 Variants Associated With VEXAS Syndrome in a Clinical Population.
Beck DB; Bodian DL; Shah V; Mirshahi UL; Kim J; Ding Y; Magaziner SJ; Strande NT; Cantor A; Haley JS; Cook A; Hill W; Schwartz AL; Grayson PC; Ferrada MA; Kastner DL; Carey DJ; Stewart DR
JAMA; 2023 Jan; 329(4):318-324. PubMed ID: 36692560
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
